×
About 133,895 results

ALLMedicine™ Type 2 Diabetes Center

Research & Reviews  42,964 results

Current status of diabetes treatment in Miyazaki Prefecture, Japan: Results of a questi...
https://doi.org/10.1111/jdi.13750
Journal of Diabetes Investigation; Uehira Y, Ueno H et. al.

Jan 20th, 2022 - The Japanese diabetes treatment guidelines do not specify the first choice of hypoglycemic agents unlike those of Western countries. Moreover, current situation in diabetes treatment is that the choice of hypoglycemic agents is determined by each ...

Longitudinal effects of one-leg standing time on neuropathy outcomes in association wit...
https://doi.org/10.1111/jdi.13751
Journal of Diabetes Investigation; Sugimoto K, Sozu T et. al.

Jan 20th, 2022 - Diabetic neuropathy leads to postural instability. This study compared longitudinal changes in neuropathy outcomes relative to long-term glycemic control in patients aged < 60 years with uncontrolled type 2 diabetes with and without a short one-le...

Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review ...
https://doi.org/10.1136/bmj-2021-067516
BMJ (Clinical Research Ed.); Jayedi A, Soltani S et. al.

Jan 20th, 2022 - To present a comprehensive review of the association between measures of body weight, waist, and fat, and different ratios of these measures, and the risk of type 2 diabetes. Systematic review and dose-response meta-analysis of cohort studies. Pub...

see more →

Guidelines  53 results

Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recomm...
https://doi.org/10.1001/jama.2021.12531
JAMA , Davidson KW et. al.

Aug 25th, 2021 - An estimated 13% of all US adults (18 years or older) have diabetes, and 34.5% meet criteria for prediabetes. The prevalences of prediabetes and diabetes are higher in older adults. Estimates of the risk of progression from prediabetes to diabetes...

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation St...
https://doi.org/10.1001/jama.2021.11922
JAMA , Davidson KW et. al.

Aug 11th, 2021 - Gestational diabetes is diabetes that develops during pregnancy. Prevalence of gestational diabetes in the US has been estimated at 5.8% to 9.2%, based on traditional diagnostic criteria, although it may be higher if more inclusive criteria are us...

Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary ...
https://doi.org/10.1016/j.numecd.2021.04.014
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Chiodini I, Gaudio A et. al.

Jun 2nd, 2021 - Bone fragility is increasingly recognized as a relevant complication of type 2 diabetes (T2D) and diabetic patients with fragility fractures have higher mortality rates than non diabetic individuals or diabetic patients without fractures. However,...

Latin American Association for the study of the liver (ALEH) practice guidance for the ...
https://doi.org/10.1016/j.aohep.2020.09.006
Annals of Hepatology; Arab JP, Dirchwolf M et. al.

Oct 9th, 2020 - Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20-30% of the general population. Furthermore, its prevalence is predicted to increase ex...

Walking for subjects with type 2 diabetes: A systematic review and joint AMD/SID/SISMES...
https://doi.org/10.1016/j.numecd.2020.08.021
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Moghetti P, Balducci S et. al.

Oct 2nd, 2020 - Regular exercise is considered a cornerstone in the management of type 2 diabetes mellitus (T2DM). It improves glucose control and cardiovascular risk factors, contributes to weight loss, and also improves general well-being, likely playing a role...

see more →

Drugs  1,427 results see all →

Clinicaltrials.gov  2,542 results

Counterfactual Strategies, Physical Activity, and Wearable Trackers
https://clinicaltrials.gov/ct2/show/NCT05192226

Jan 14th, 2022 - A.1 Significance A.1.1 Physical Activity. The CDC suggests that 150-300 minutes of moderate-intensity physical activity (PA) is important to staving off non-communicable diseases (NCD) such as cancer, type 2 diabetes, and comorbidity health outcom...

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES
https://clinicaltrials.gov/ct2/show/NCT03433248

Jan 14th, 2022 - Sodium-glucose linked transporters (SGLT-2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors are relatively novel glucose-lowering drugs for the treatment of T2DM. These agents seem to exert pleiotropic actions 'beyond glucose control'. SG...

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT05144984

Jan 13th, 2022 - This study is looking at semaglutide in combination with a potential new medicine (NNC0480-0389) in people with type 2 diabetes. The study is being conducted to see how well semaglutide, in combination with different doses of NNC0480-0389, work to...

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
https://clinicaltrials.gov/ct2/show/NCT05035082

Jan 13th, 2022 - This study is comparing the medicine RYBELSUS® to other medicines in people with type 2 diabetes who need extra treatment. All medicines used in this study are tablets which lower blood sugar in people with type 2 diabetes. The purpose of the stud...

Cross-Sectional and Longitudinal Studies of "Pre-Diabetes" in the Pima Indians
https://clinicaltrials.gov/ct2/show/NCT00340132

Jan 12th, 2022 - Insulin resistance and a defect in early insulin secretion are risk factors for the development of type 2 diabetes mellitus. A recent longitudinal analysis which tracked the development of diabetes demonstrated that both insulin action and early i...

see more →

News  6,525 results

Rapid Rx Quiz: Semaglutide
https://www.medscape.com/viewarticle/966885

Jan 20th, 2022 - Called a "game changer" weight loss drug by some experts, semaglutide is the first such medication approved by the US Food and Drug Administration since 2014. Semaglutide, specifically the brand Wegovy, is indicated for use in adults with obesity ...

Higher Cardiorespiratory Fitness Cuts Incident Diabetes Risk 
https://www.medscape.com/viewarticle/966702

Jan 17th, 2022 - The study covered in this summary is a preprint and has not yet been peer reviewed. Key Takeaways The results document a strong, inverse relationship between cardiorespiratory fitness and new-onset type 2 diabetes in a study of more than 8700 peop...

More Hospital Admissions Due to Being Overweight Than Thought
https://www.medscape.com/viewarticle/966714

Jan 17th, 2022 - It has long been recognised that those people who are overweight/obese attend hospital more frequently than those who maintain a healthy weight. Now researchers from Bristol Medical School’s Population Health Science Institute have suggested that ...

Disparities in GLP-1 Receptor Agonist Use in Type 2 Diabetes
https://www.medscape.com/viewarticle/966590

Jan 14th, 2022 - (Reuters Health) - White and more affluent patients with type 2 diabetes are significantly more likely to receive glucagon-like peptide-1 (GLP-1) receptor agonist therapy than individuals who are Black, Asian, Hispanic or low-income, a U.S. study ...

After Initial Dip, Dementia Risk Rises With Diabetes Duration
https://www.medscape.com/viewarticle/966461

Jan 13th, 2022 - NEW YORK (Reuters Health) - A new study shows dementia risk follows a U-shape curve after a diagnosis of type 2 diabetes, dropping for nearly five years and then rising again with longer disease duration. "We identified a non-linear association of...

see more →

Patient Education  47 results see all →